Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Free Cash Flow: 2009-2025

Historic Free Cash Flow for BIO-TECHNE (TECH) over the last 16 years, with Sep 2025 value amounting to $22.2 million.

  • BIO-TECHNE's Free Cash Flow fell 59.39% to $22.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $224.1 million, marking a year-over-year decrease of 8.56%. This contributed to the annual value of $256.6 million for FY2025, which is 8.66% up from last year.
  • Latest data reveals that BIO-TECHNE reported Free Cash Flow of $22.2 million as of Q3 2025, which was down 76.19% from $93.3 million recorded in Q2 2025.
  • BIO-TECHNE's 5-year Free Cash Flow high stood at $110.7 million for Q2 2021, and its period low was $22.2 million during Q3 2025.
  • Over the past 3 years, BIO-TECHNE's median Free Cash Flow value was $57.5 million (recorded in 2024), while the average stood at $56.9 million.
  • Per our database at Business Quant, BIO-TECHNE's Free Cash Flow surged by 303.76% in 2021 and then plummeted by 59.39% in 2025.
  • Over the past 5 years, BIO-TECHNE's Free Cash Flow (Quarterly) stood at $90.8 million in 2021, then slumped by 35.84% to $58.3 million in 2022, then rose by 17.12% to $68.3 million in 2023, then increased by 13.59% to $77.5 million in 2024, then slumped by 59.39% to $22.2 million in 2025.
  • Its last three reported values are $22.2 million in Q3 2025, $93.3 million for Q2 2025, and $31.0 million during Q1 2025.